Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hojnacki

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Acta Medica Austriaca|January 1, 1991
[Value of hemodilution therapy in pregnancy]L Heilmann, B Hojnacki
Zeitschrift Fur Geburtshilfe Und Perinatologie|July 1, 1991
[Changes in plasma coagulation and fibrinolysis following cesarean section and relationship to deep venous thrombosis. Results of a randomized prospective comparative study with 6% hydroxyethyl starch 0.62 and low-dose heparin as thrombosis prophylaxis]L Heilmann, B Hojnacki, C Ose
Geburtshilfe Und Frauenheilkunde|March 1, 1991
[Hemostasis and pre-eclampsia]L Heilmann, B Hojnacki, E Spanuth
Zeitschrift Fur Geburtshilfe Und Perinatologie|November 1, 1990
[Deep venous thrombosis in pregnancy: risk factors and possibilities for prevention]L Heilmann, B Hojnacki, W M Fischer
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 19, 2006
Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VIIL Heilmann, C Wild, B Hojnacki, et al.
Gynecologic and Obstetric Investigation|January 1, 1994
Red cell deformability in gestational hypertensionL Heilmann, B Hojnacki, G F von Tempelhoff
Infusionstherapie (Basel, Switzerland)|October 1, 1991
[Accumulation of two different hydroxyethyl starch preparations in the placenta after hemodilution in patients with fetal intrauterine growth retardation or pregnancy hypertension]L Heilmann, E Lorch, B Hojnacki, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie|March 1, 1993
[Clinical experiences with passive immunotherapy in habitual abortion]L Heilmann, A Kriechbaum, B Hojnacki, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1993
[Hemoglobin--an obstetric risk factor]L Heilmann, B Hojnacki, B Herrle, et al.
Journal of Reproductive Immunology|July 1, 1991
Fc receptor blocking antibodies after active immunization for the treatment of recurrent spontaneous abortionU Kuhn, R Blasczyk, B Hojnacki, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Acta Medica Austriaca|January 1, 1991
[Value of hemodilution therapy in pregnancy]L Heilmann, B Hojnacki
Zeitschrift Fur Geburtshilfe Und Perinatologie|July 1, 1991
[Changes in plasma coagulation and fibrinolysis following cesarean section and relationship to deep venous thrombosis. Results of a randomized prospective comparative study with 6% hydroxyethyl starch 0.62 and low-dose heparin as thrombosis prophylaxis]L Heilmann, B Hojnacki, C Ose
Geburtshilfe Und Frauenheilkunde|March 1, 1991
[Hemostasis and pre-eclampsia]L Heilmann, B Hojnacki, E Spanuth
Zeitschrift Fur Geburtshilfe Und Perinatologie|November 1, 1990
[Deep venous thrombosis in pregnancy: risk factors and possibilities for prevention]L Heilmann, B Hojnacki, W M Fischer
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 19, 2006
Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VIIL Heilmann, C Wild, B Hojnacki, et al.
Gynecologic and Obstetric Investigation|January 1, 1994
Red cell deformability in gestational hypertensionL Heilmann, B Hojnacki, G F von Tempelhoff
Infusionstherapie (Basel, Switzerland)|October 1, 1991
[Accumulation of two different hydroxyethyl starch preparations in the placenta after hemodilution in patients with fetal intrauterine growth retardation or pregnancy hypertension]L Heilmann, E Lorch, B Hojnacki, et al.
Zeitschrift Fur Geburtshilfe Und Perinatologie|March 1, 1993
[Clinical experiences with passive immunotherapy in habitual abortion]L Heilmann, A Kriechbaum, B Hojnacki, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1993
[Hemoglobin--an obstetric risk factor]L Heilmann, B Hojnacki, B Herrle, et al.
Journal of Reproductive Immunology|July 1, 1991
Fc receptor blocking antibodies after active immunization for the treatment of recurrent spontaneous abortionU Kuhn, R Blasczyk, B Hojnacki, et al.
Pageof 1